MHRA Approves Linerixibat For Biliary Itch
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Linerixibat, marketed as Lynavoy, for treating itch caused by biliary tract disease.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Bluesky Social
“MHRA approves Linerixibat (Lynavoy) for the treatment of itch due to biliary tract disease”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade